Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
about
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL ExpressionKnown glioma risk loci are associated with glioma with a family history of brain tumours--a case-control gene association studyRisk factors for oligodendroglial tumors: a pooled international studyAssociation between adult height, genetic susceptibility and risk of gliomaPersonal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studiesJoint effects between five identified risk variants, allergy, and autoimmune conditions on glioma riskGenome-wide association study of glioma and meta-analysisJoint associations between genetic variants and reproductive factors in glioma risk among womenGenetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifsFurther confirmation of germline glioma risk variant rs78378222 in TP53 and its implication in tumor tissues via integrative analysis of TCGA dataA subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traitsTRF2 recruits RTEL1 to telomeres in S phase to promote t-loop unwindingReplication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer ConsortiumRecent advances in the molecular understanding of glioblastomaLong Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular DiseaseAssociation between XRCC1 polymorphism 399 G->A and glioma among Caucasians: a systematic review and meta-analysis.The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studiesInflammatory mechanisms linking periodontal diseases to cardiovascular diseasesMolecular functions and cellular roles of the ChlR1 (DDX11) helicase defective in the rare cohesinopathy Warsaw breakage syndromeRTEL1 (regulator of telomere elongation helicase 1), a DNA helicase essential for genome stabilityEmerging critical roles of Fe-S clusters in DNA replication and repair.The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomideTelomere maintenance and the etiology of adult gliomaA RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han ChineseTelomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysisGenetic polymorphisms in the 9p21 region associated with risk of multiple cancersRTEL1 tagging SNPs and haplotypes were associated with glioma developmentThe Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International ConsortiumInherited variation in immune genes and pathways and glioblastoma riskAssociation between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control StudyRecurrent epimutations activate gene body promoters in primary glioblastomaMeta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian womenAssociation between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysisHigh frequency of the X-chromosome inactivation in young female patients with high-grade gliomaReproductive factors and risk of primary brain tumors in womenA genetic variant in the APE1/Ref-1 gene promoter -141T/G may modulate risk of glioblastoma in a Chinese Han population.The epidemiology of glioma in adults: a "state of the science" reviewTraumatic brain injury and subsequent glioblastoma development: Review of the literature and case reportsUnderstanding inherited genetic risk of adult glioma - a reviewGenetics in glioma: lessons learned from genome-wide association studies
P2860
Q21092443-B1BBBA0F-4661-4958-AE0C-DF35357A21E3Q23910347-FFE7FA59-6103-465A-A345-E7C9B7A2CA01Q23910577-535B5BB0-D0D3-424E-90B7-69189D5D062DQ23910819-B2E5044F-DD5E-4FC3-A36F-C63A5FD6BCE4Q23910820-80475EA3-31E8-4652-9AA1-B3DE381EF1ACQ23917504-F85AB5C6-900D-480B-A86A-C3206AD4E190Q23919638-81B8AAD2-1E0D-4F6C-A6C7-08488818EECBQ23921519-16915CAC-7B38-4F29-BA0C-7DCAD11AE326Q23923585-5FCC8C28-81D1-4EB3-86F5-984D9CDB75BFQ23924182-6A5755AB-886C-4480-B501-0495904FA491Q24169696-9DD17059-7FCE-4C80-8E44-6FC868F21DB4Q24316035-7DA1B21B-DB74-4BCC-8693-20171D6D3A8EQ24618707-8C322FB2-FC64-43D8-9045-017B6B16BBC1Q24632928-3E7783F9-6B93-4753-8275-95F15F4BC4DAQ26798251-E1C4BDB1-8B68-4EE4-B815-C122E7452AE0Q26827363-124FC1F1-8054-4518-BF0D-70564AFD4F54Q26830803-066E1815-93DB-4AE0-A28C-9703DE320EADQ26997381-B4BDEEA5-0842-425A-AC1F-AD6F502DAB72Q27016169-7ACA6FDD-DB70-4FCF-B848-F34E79EB198BQ27026906-6D104B80-9AF6-4C0E-B79F-39FF8DB63359Q27332013-69A43AE8-79D4-42BD-A17A-63BB672B5C13Q27853156-F3B915E7-E164-4B87-8104-0761278792BEQ28084275-43ADFAFC-7C2A-4FD9-AE0A-4308A8536E2EQ28243683-B7999972-AB18-4FD6-82F8-60DC51A09EAFQ28265076-92A15DD6-68EC-4C05-8812-6AB71DE98E48Q28383262-A93095D2-A218-4D26-8442-5B2826FCB747Q28383341-3D648675-34AA-4A4D-B214-4F238A589411Q28383443-0D9F9BEA-70E6-43FD-BA27-F7EDE8A3AAC8Q28383820-9E6CD0D8-0B91-4030-A78A-E542C4C447E4Q28383907-311A620C-4FB1-44A9-93FF-1474CAE60CFFQ28385236-EBB7E1E3-F0B7-465B-A835-E14EE51924A4Q28385292-E5AA7872-B78F-4589-A69B-3C7F2EB5E0E5Q28386013-85F12E0B-60A8-4374-AE66-D57EC7787C76Q28387295-68AF4053-2B7D-457B-90F3-8588EF9177A0Q28387379-C9583A7F-8715-4F8E-AFB0-4399BB0E0801Q28387660-6DA4D466-C006-458F-B475-9DEFF09EE8A0Q28387839-C8291CC3-DA00-4B84-B67D-444FECDD6FE7Q28388337-995877FE-6B88-40E5-949D-E789C04F8D1EQ28388566-2548AD75-A3FE-4FB9-ACBA-1E6794FAD6E0Q28388951-0FBDDC94-521D-4E49-80BC-424A8B0F7461
P2860
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@ast
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@en
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@nl
type
label
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@ast
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@en
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@nl
prefLabel
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@ast
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@en
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@nl
P2093
P2860
P3181
P356
P1433
P1476
Variants in the CDKN2B and RTE ...... gh-grade glioma susceptibility
@en
P2093
Amanda L Rynearson
Brian P O'Neill
Caterina Giannini
Chandralekha Halder
Charles Quesenberry
Daniel H LaChance
Ivan Smirnov
Jan C Buckner
Jeffrey S Chang
Joe Patoka
P2860
P2888
P3181
P356
10.1038/NG.408
P407
P577
2009-08-01T00:00:00Z
P5875
P6179
1019657607